Clinical trial
Postoperative Safety Outcomes in Patients Undergoing Routine Phacoemulsification Cataract Surgery With Intraoperative Intracameral Injection of Preservative-Free Moxifloxacin Versus Levofloxacin
NCT04403334 is registered in ClinicalTrials.gov with Peregrine Eye and Laser Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postoperative Safety Outcomes in Patients Undergoing Routine Phacoemulsification Cataract Surgery With Intraoperative Intracameral Injection of Preservative-Free Moxifloxacin Versus Levofloxacin
- Lead sponsor
- Peregrine Eye and Laser Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 2, 2018
- Completion date
- April 28, 2018
- Enrollment
- 114 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antibiotic side effect, cataract senile, endophthalmitis, safety issues